Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-31 @ 12:56 PM
Study NCT ID:
NCT00053833
Status:
TERMINATED
Last Update Posted:
2013-11-08
First Post:
2003-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2004-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-07
Completion Date Type:
ACTUAL
First Submit Date:
2003-02-05
First Submit QC Date:
None
Study First Post Date:
2003-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-07
Last Update Post Date:
2013-11-08
Last Update Post Date Type:
ESTIMATED